Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 26, 2025JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIAOpen Access

Efficacy of Ticagrelor Monotherapy in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: a Systematic Review

View Full Paper
Ask AI
Bookmark
Share

Authors

EAErlita Nur ArifanaBZBambang Subakti Zulkarnain

Discussion

Loading...

Member takes

Overview

Systematic review evaluates ticagrelor monotherapy's effects on patients with high bleeding risk after PCI, suggesting possible benefits.

Key Points

  • Ticagrelor monotherapy after dual antiplatelet therapy could reduce bleeding risk in high-risk patients.
  • Clinical outcomes assessed included all-cause mortality and stroke over a follow-up of up to one year.
  • This systematic review followed PRISMA guidelines, analyzing six relevant studies focused on ticagrelor and PCI.
  • The findings may guide healthcare decisions balancing the risks and benefits of antiplatelet strategies.

Cite This Study

Arifana et al. (2025) studied this question.

synapsesocial.com/papers/68d6cd5bb1249cec298b329dhttps://doi.org/10.20473/jfiki.v12i22025.174-194
View Full Paper
Ask AI
Bookmark
Share